首页
登录
职称英语
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
游客
2024-04-30
16
管理
问题
A personalized blood test that can identify tumor(肿瘤)DNA could be the first step towards a long-promised revolution in the way cancer is treated.
In the short term, the test—reported by Victor Velculescu of Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, and his colleagues in Science Translational Medicine—could be used to spot cancer recurrence before tumor growth shows up on scans, meaning that treatment could be started earlier.
The test detects genetic rearrangements that distinguish cancer cells from normal cells. Eventually it might also pave the way for more personalized cancer treatments tailored to the genetic signature of individuals’ tumors.
Doctors already classify cancers by some of the genes that get switched on by the disease, and use this to guide treatment in some cases. For example, breast cancers are often divided into those that express oestrogen(雌激素)receptors on their surface and are therefore likely to respond to the drug tamoxifen(三苯氧胺), and those that don’t.
Genes have also been identified that predict whether a variety of cancers are resistant to radiotherapy and certain drugs, and might therefore need a different sort of treatment. It is also possible to stratify(使分层)cancers into aggressive and non-aggressive subtypes(类型)according to their genetic make-up.
But that’s just the beginning. In the future, pretty much all cancers are likely to be defined by the genetic pathways that drive their growth, rather than where in the body they manifest themselves. And because cancers mutate as they grow, it should be possible to track these changes and tailor patients’ therapies accordingly.
Velculescu’s test is a step towards this. The real breakthrough will come when such blood tests become sophisticated enough to reveal how tumors are changing over time, rather than simply spotting that they have come back. That should truly revolutionize cancer treatment, enabling the most effective combinations of drugs to be tailored to individual patients—and without the need for painful tissue biopsies(生检采样). [br] According to the passage, cancer cells and normal cells can be separated by the test due to its ability to find out______.
选项
答案
genetic rearrangement
解析
本题考查该检测手段的具体功能。定位句指出,该血液检测可发现基因重组,而这能够将癌细胞和正常细胞区分开。题干中的find out与原文中的detects意思相同,因此detects之后的宾语genetic rearrangement就是本题答案。
转载请注明原文地址:http://tihaiku.com/zcyy/3577807.html
相关试题推荐
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
随机试题
Peoplewhobecomedeafor【C1】______ofhearinginadultlifehavedifferent
Howmenfirstlearnedtoinventwordsisunknown:inotherwords,theorigin
下列哪个因素不能使人群易感性增加()A.新生儿增加 B.易感人口的迁入
()是指导党和人民实现中华民族伟大复兴的正确理论。A.中国特色社会主义道路
患者,女,60岁。晨起家人发现其不能讲话,但似能听懂他人的讲话内容,能随命令做相
患者,女,18岁。过食生冷后腹泻,腹痛肠鸣,大便恶臭,泻后痛减,伴有未消化食物,
产生促红细胞生成素的主要器官是A.脾脏 B.骨髓 C.肺 D.肝脏 E.
绿色食品是指产自优良环境,按照规定的技术规范生产,实行全程质量控制,无污染、安全
拟定具体物业经营管理项目和内容时,首先要考虑现有物业管理服务内容等资源是否能够促
青年土耳其党
最新回复
(
0
)